Table 3

Adverse events reported by study participants

Adverse eventSLE (N=50)Controls (N=50)Total (N=100)
Erythema and pain at injection site3 (6%)2 (4%)5 (5%)
Rash1 (2%)0 (0%)1 (1%)
Nausea1 (2%)0 (0%)1 (1%)
Headache1 (2%)1 (2%)2 (2%)
Irregular menses1 (2%)1 (2%)2 (2%)
Upper respiratory tract infection1 (2%)1 (2%)2 (2%)
  • SLE, systemic lupus erythematosus.